
Johnson & Johnson
Stage
DivestiturePortfolio Exits
58Investments
120Funding, Valuation & Revenue
1 Fundings
Johnson & Johnson's latest funding round was a IPO for on September 24, 1944.
Johnson & Johnson Acquisitions
71 Acquisitions
Johnson & Johnson acquired 71 companies. Their latest acquisition was Halda Therapeutics on November 17, 2025.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
11/17/2025 | Series B | $226.21M | Acquired | 7 | ||
9/3/2025 | Other | $0.35M | Acquired | 2 | ||
7/25/2025 | Erickson-Larsen | Acquired | 1 | |||
4/2/2025 | Other | |||||
8/20/2024 | Series C |
Date | 11/17/2025 | 9/3/2025 | 7/25/2025 | 4/2/2025 | 8/20/2024 |
|---|---|---|---|---|---|
Investment Stage | Series B | Other | Other | Series C | |
Companies | Erickson-Larsen | ||||
Valuation | |||||
Total Funding | $226.21M | $0.35M | |||
Note | Acquired | Acquired | Acquired | ||
Sources | 7 | 2 | 1 |
Johnson & Johnson Investments
120 Investments
Johnson & Johnson has made 120 investments. Their latest investment was in Sensori as part of their Seed on August 06, 2025.
Johnson & Johnson Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/6/2025 | Seed | Sensori | $0.1M | Yes | 19 Keys, Block, Crystal Chanel, and Undisclosed Angel Investors | 2 |
12/12/2024 | Seed VC - III | Alessa Therapeutics | $15M | Yes | 2 | |
11/11/2024 | Pre-Seed | Eldie | Yes | 1 | ||
7/16/2024 | Series C | |||||
4/17/2023 | Grant - III |
Date | 8/6/2025 | 12/12/2024 | 11/11/2024 | 7/16/2024 | 4/17/2023 |
|---|---|---|---|---|---|
Round | Seed | Seed VC - III | Pre-Seed | Series C | Grant - III |
Company | Sensori | Alessa Therapeutics | Eldie | ||
Amount | $0.1M | $15M | |||
New? | Yes | Yes | Yes | ||
Co-Investors | 19 Keys, Block, Crystal Chanel, and Undisclosed Angel Investors | ||||
Sources | 2 | 2 | 1 |
Johnson & Johnson Portfolio Exits
58 Portfolio Exits
Johnson & Johnson has 58 portfolio exits. Their latest portfolio exit was Depuy Synthes on February 19, 2026.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/19/2026 | Divestiture | Acquirer | 2 | ||
9/11/2025 | Divestiture | Stugeron | 2 | ||
5/4/2023 | Spinoff / Spinout | Kenvue | 2 | ||
Date | 2/19/2026 | 9/11/2025 | 5/4/2023 | ||
|---|---|---|---|---|---|
Exit | Divestiture | Divestiture | Spinoff / Spinout | ||
Companies | Stugeron | Kenvue | |||
Valuation | |||||
Acquirer | Acquirer | ||||
Sources | 2 | 2 | 2 |
Compare Johnson & Johnson to Competitors
Boehringer Ingelheim operates as a healthcare company involved in the development of pharmaceuticals and biopharmaceuticals. The company offers products and services for human and animal health, including therapeutic solutions and veterinary medicines, primarily serving the healthcare and veterinary sectors. It was founded in 1885 and is based in Ingelheim am Rhein, Germany.

Servier operates as a global pharmaceutical group focusing on therapeutic advancements in the healthcare sector. The company specializes in developing treatments for cardiometabolism, oncology, and neurology. Servier also produces a range of generic drugs and maintains a focus on patient needs throughout various stages of the medicine life cycle. It was founded in 1954 and is based in Suresnes, France.

Gore manufactures medical devices within the healthcare sector. The company offers medical devices that use fluoropolymer technology to address various medical problems, including aortic, cardiac, peripheral, and surgical needs. Gore serves healthcare professionals and institutions that require medical technologies to support patient care. It was founded in 1958 and is based in Newark, Delaware.

Lion is a company that operates in the consumer goods sector, providing personal care products, household cleaning agents, and healthcare items. The company also conducts research and development for sustainable materials and healthcare solutions. It was founded in 1918 and is based in Tokyo, Japan.

Aveta System specializes in minimally invasive hysteroscopic procedures within the medical technology sector. The company offers a tissue removal solution for intrauterine pathology, featuring a suite that includes an integrated camera with rotation, automatic image orientation lock, and fluid management for patient care. Aveta System is intended for use in medical settings, providing physicians with tools to perform fibroid and polyp removal, as well as diagnostic and therapeutic interventions. It was founded in 2016 and is based in San Jose, California.
B. Braun operates as a medical technology company that specializes in infusion therapy, pain management, and other healthcare products and services. The company offers products including smart infusion pumps, intravenous (IV) fluids, irrigation solutions, automated compounding, clinical nutrition solutions, and devices for regional anesthesia and acute pain management. B. Braun primarily serves the healthcare industry, with a focus on patient care and safety through its medical technologies. It was founded in 1839 and is based in Bethlehem, Pennsylvania.
Loading...

